The Life Sciences Report

Recent Articles

Eight Ways to Leverage the Small-Cap Biotech Bull Market

SeeThruEquity's Ajay Tandon and Jay Albany are riding the biotech bull by harnessing the huge upside potential of these micro-cap companies

14 Small-Cap Biotech Stocks to Watch in 2015

Reporting a drop in the value of the small-cap biotech stocks is always rough.

Sunesis Pharmaceuticals: Battle Cancer and Enhance Investments

Sunesis Pharmaceuticals' Vosaroxin will be leading the charge, hopefully gaining regulatory traction both in the U.S. and the European Union.

Should Biotech Investors Target the Takeouts?

A small company developing a drug that requires significant commercial investment upon launch either requires a larger commercial partner or is a takeout target.

3 Biotechs That Could Radically Change the Medicine Forever

In the next two to three years, we are going to see whether we really can fix diseases by driving the body to do the repairs, instead of adding products into the body to handle the symptoms of disease.